Karl R. Gibson

1.1k total citations
27 papers, 796 citations indexed

About

Karl R. Gibson is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karl R. Gibson has authored 27 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karl R. Gibson's work include Asymmetric Synthesis and Catalysis (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Synthesis and biological activity (3 papers). Karl R. Gibson is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Synthetic Organic Chemistry Methods (4 papers) and Synthesis and biological activity (3 papers). Karl R. Gibson collaborates with scholars based in United Kingdom, United States and Belgium. Karl R. Gibson's co-authors include Ian Paterson, Renata M. Oballa, Debra J. Wallace, David Y.‐K. Chen, Mark J. Coster, James E. Mills, Gavin A. Whitlock, Peter J. Bungay, José Luis Aceña and Jordi Bach and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Karl R. Gibson

25 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl R. Gibson United Kingdom	15	460	255	164	96	72	27	796
R. Satheesh Babu India	17	948 2.1×	522 2.0×	74 0.5×	153 1.6×	21 0.3×	28	1.2k
Marc M. Kurtz United States	17	389 0.8×	750 2.9×	77 0.5×	152 1.6×	303 4.2×	36	1.3k
CARMEN DRAHL United States	10	331 0.7×	336 1.3×	109 0.7×	176 1.8×	13 0.2×	79	749
Eric A. Wold United States	16	512 1.1×	900 3.5×	29 0.2×	111 1.2×	176 2.4×	31	1.5k
Takahiko Taniguchi Japan	22	1.1k 2.4×	649 2.5×	89 0.5×	181 1.9×	26 0.4×	78	1.5k
Pilar López‐Alvarado Spain	18	732 1.6×	247 1.0×	26 0.2×	105 1.1×	25 0.3×	53	976
Narsimha Reddy Penthala United States	21	578 1.3×	440 1.7×	17 0.1×	155 1.6×	78 1.1×	85	1.1k
Sharan K. Bagal United Kingdom	14	296 0.6×	582 2.3×	29 0.2×	78 0.8×	178 2.5×	20	938
Ronald C. Bernotas United States	19	951 2.1×	549 2.2×	57 0.3×	130 1.4×	75 1.0×	43	1.2k
Michel Thérien Canada	20	526 1.1×	452 1.8×	33 0.2×	219 2.3×	39 0.5×	34	1.0k

Countries citing papers authored by Karl R. Gibson

Since Specialization

Citations

This map shows the geographic impact of Karl R. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl R. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl R. Gibson more than expected).

Fields of papers citing papers by Karl R. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl R. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl R. Gibson. The network helps show where Karl R. Gibson may publish in the future.

Co-authorship network of co-authors of Karl R. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Karl R. Gibson. A scholar is included among the top collaborators of Karl R. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl R. Gibson. Karl R. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benn, Caroline, Karl R. Gibson, & David S. Reynolds. (2020). Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases. Journal of Huntington s Disease. 10(1). 203–220. 19 indexed citations

Tozer, Matthew J., Karl R. Gibson, Paul A. Glossop, et al.. (2020). Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor. ACS Pharmacology & Translational Science. 3(4). 706–719. 13 indexed citations

Russell, Rachel, Kim Tang, Kelly A. Allers, et al.. (2018). Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents. The Journal of Sexual Medicine. 15(12). 1698–1706. 13 indexed citations

Osterloh, I., et al.. (2017). PS-04-004 The Pharmacological Profile of IX-01, A Selective Oxytocin Receptor Antagonist being Developed to Treat Men with Premature Ejaculation. The Journal of Sexual Medicine. 14(Supplement_4a). e117–e117. 3 indexed citations

Skerratt, S., Mark D. Andrews, Sharan K. Bagal, et al.. (2016). The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain. Journal of Medicinal Chemistry. 59(22). 10084–10099. 58 indexed citations

Bagal, Sharan K., Peter J. Bungay, Karl R. Gibson, et al.. (2015). Discovery and Optimization of Selective Na _v 1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain. ACS Medicinal Chemistry Letters. 6(6). 650–654. 36 indexed citations

Glossop, Paul A., Gavin A. Whitlock, & Karl R. Gibson. (2015). Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 – 2014). Expert Opinion on Therapeutic Patents. 25(7). 743–754.

Desai, Bimbisar, Karen Dixon, Elizabeth Farrant, et al.. (2013). Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform. Journal of Medicinal Chemistry. 56(7). 3033–3047. 102 indexed citations

Howe, David, Natalie Mount, Amy Brown, et al.. (2011). The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human. Journal of Pharmacology and Experimental Therapeutics. 339(2). 642–653. 1 indexed citations

10.

Bungay, Peter J., et al.. (2011). Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist. Drug Metabolism and Disposition. 39(8). 1396–1405. 18 indexed citations

11.

Underwood, Toby J., et al.. (2010). Synthetic Studies on a Nonsteroidal Progesterone Metabolite: Regioselective N-Alkylation of an Activated Pyrazole. Synlett. 2010(6). 873–876. 1 indexed citations

12.

Mantell, Simon J., Karl R. Gibson, Simon A. Osborne, et al.. (2009). In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(8). 2190–2194. 12 indexed citations

13.

Brown, Lynda J., et al.. (2008). Total Synthesis of cis-Sylvaticin. Organic Letters. 10(12). 2489–2492. 25 indexed citations

14.

Jelley, Richard A., Jason Elliott, Karl R. Gibson, et al.. (2006). 3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity. Bioorganic & Medicinal Chemistry Letters. 16(14). 3839–3842. 14 indexed citations

15.

Paterson, Ian, Mark J. Coster, David Y.‐K. Chen, Karl R. Gibson, & Debra J. Wallace. (2005). The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the CD-spiroacetal segment. Organic & Biomolecular Chemistry. 3(13). 2410–2410. 43 indexed citations

16.

Crawforth, James, John Atack, Susan M. Cook, et al.. (2004). Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands. Bioorganic & Medicinal Chemistry Letters. 14(7). 1679–1682. 11 indexed citations

17.

Gibson, Karl R., Laure Hitzel, Russell J. Mortishire‐Smith, et al.. (2002). Synthesis and Conformational Dynamics of Tricyclic Pyridones Containing a Fused Seven-Membered Ring. The Journal of Organic Chemistry. 67(26). 9354–9360. 31 indexed citations

18.

Paterson, Ian, David Y.‐K. Chen, Mark J. Coster, et al.. (2001). Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1 Financial support was provided by the EPSRC (GR/L41646), Cambridge Commonwealth Trust (Scholarship to M.J.C.), EC (Marie Curie Postdoctoral Fellowship to J.L.A.), DFG (Postdoctoral Fellowship to T.T.), NSERC-Canada (Postdoctoral Fellowship to R.M.O.), Churchill College (Research Fellowship to D.J.W.), Kingapos;s College and Sims Fund, Cambridge (Scholarship to D.Y.K.C.). We also thank Merck and AstraZeneca Pharmaceuticals for generous support, and Dr. Anne Butlin (AZ) and Dr. Nick Bampos (Cambridge) for valuable assistance.. Angewandte Chemie International Edition. 40(21). 4055–4055. 94 indexed citations

19.

Paterson, Ian, Debra J. Wallace, & Karl R. Gibson. (1997). Studies in marine macrolide synthesis: Synthesis of a C16C28 subunit of spongistatin 1 (altohyrtin A) incorporating the CD-spiroacetal moiety. Tetrahedron Letters. 38(51). 8911–8914. 53 indexed citations

20.

Paterson, Ian, Karl R. Gibson, & Renata M. Oballa. (1996). Remote, 1,5-anti stereoinduction in the boron-mediated aldol reactions of β-oxygenated methyl ketones. Tetrahedron Letters. 37(47). 8585–8588. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact